MedTrace Logo

Enhanced Recovery Protocols in Gynecologic Oncology

NCT06655506 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2024-10-23

No results posted yet for this study

Summary

Enhanced Recovery After Surgery (ERAS) are developed to provide a systematic structure for managing postsurgical patients.These protocols promote evidenced-based practices and implement a multidisciplinary effort to maintain normal physiology in the perioperative period and aid in earlier recovery. The present study aims to investigate the feasibility of and compliance to a structured ERAS protocol among Gynecological Oncological Centers in Greece as well as to compare the outcomes among patients that fullfilled the minimum number of necessary criteria, compared to those that were enrolled in ERAS protocols but did not meet the sufficient necessary criteria.

Conditions

  • ERAS
  • Gynecologic Cancer
  • Perioperative Complication
  • Postoperative Pain
  • Quality of Life
  • Infections

Interventions

COMBINATION_PRODUCT

ERAS group

This group will include patients that achieved a compliance rate that exceeded 80% of the required predetermined criteria of ERAS protocols.

COMBINATION_PRODUCT

Control group

This group will include patients that do not follow the predetermined criteria of ERAS protocols

Sponsors & Collaborators

  • University of Thessaly

    collaborator OTHER

  • Aristotle University Of Thessaloniki

    collaborator OTHER

  • Metaxa Hospital

    collaborator OTHER

  • Saint Savvas Anticancer Hospital

    collaborator OTHER

  • National and Kapodistrian University of Athens

    lead OTHER

Eligibility

Min Age
25 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-20
Primary Completion
2026-03-31
Completion
2026-07-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06655506 on ClinicalTrials.gov